Table 3 Expression level of p53, TNF-α, IL-6 and Presenillin-1 in the brain tissue of the negative control group and groups administered acrylamide or/and TiO2NPs.
Group | Treatment (dose mg/kg) | P53 | TNF-α | IL-6 | Presenillin-1 |
|---|---|---|---|---|---|
I | Negative control (deionized water) | 1.00 ± 0.00a | 1.00 ± 0.00a | 1.00 ± 0.00a | 1.00 ± 0.00a |
II | Acrylamide (3 mg/kg) | 4.23 ± 0.28b | 2.71 ± 0.14b | 3.35 ± 0.11b | 2.32 ± 0.07b |
III | TiO2-NPs (5 mg/kg) | 2.12 ± 0.18c | 2.06 ± 0.15c | 2.36 ± 0.07c | 1.94 ± 0.16c |
IV | Acrylamide + TiO2-NPs | 4.75 ± 0.24d | 3.59 ± 0.17d | 5.26 ± 0.23d | 2.22 ± 0.10b |
One Way Analysis of Variance | F = 214.55 P < 0.001 | F = 215.37 P < 0.001 | F = 541.18 P < 0.001 | F = 105.51 p < 0.001 | |